Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Moran Sean F.
Relationship:   Chief Financial Officer
City:   Columbia
State:   MD
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   143,605    

Indirect Shares

   0      
Direct Value   $2,269,764    

Indirect Value

   $0      
Total Shares   143,605      
Total Value   $2,269,764      


Celsion Corp $49,700 Invivo Therapeutics Holdings Corporation $23,118 Corbus Pharmaceuticals Holdings, Inc. $2,196,946 Celsion Corp $49,700 Invivo Therapeutics Holdings Corporation $23,118 Corbus Pharmaceuticals Holdings, Inc. $2,196,946
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    3   
    0    

     Stock price went up :
    1   
    0    
     Stock price went down :
    2   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
   1,046.1%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Celsion Corp CLSN Chief Financial Officer 2009-03-17 35,000 2009-01-19 0    Premium*  
            Invivo Therapeutics Holdings Cor... NVIV Acting Chief Financial... 2013-09-03 60,000 2013-08-29 0    Premium*  
            Corbus Pharmaceuticals Holdings,... CRBP Chief Financial Officer 2024-04-10 48,605 2014-11-25 0    Premium*  
* Premium Members only  

Records found :    61         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 3
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
CLSN Celsion Corp Chief Financial Officer   •       –      –    2008-12-08 4 A $3.00 $75,000 D/D 25,000 25,000 0 -
CLSN Celsion Corp Chief Financial Officer   •       –      –    2009-01-19 4 A $2.72 $13,600 D/D 5,000 30,000 0 -
CLSN Celsion Corp Chief Financial Officer   •       –      –    2009-03-17 4 B $2.40 $12,000 D/D 5,000 35,000 2.74 -
NVIV Invivo Therapeutics Holdi... Acting Chief Financial Officer   •       –      –    2013-08-29 4 S $1.23 $34,440 D/D (28,000) 28,000 0 -
NVIV Invivo Therapeutics Holdi... Acting Chief Financial Officer   •       –      –    2013-08-29 4/A B $1.23 $34,440 D/D 28,000 28,000 2.74 -
NVIV Invivo Therapeutics Holdi... Acting Chief Financial Officer   •       –      –    2013-08-30 4 S $1.47 $17,640 D/D (12,000) 40,000 0 -
NVIV Invivo Therapeutics Holdi... Acting Chief Financial Officer   •       –      –    2013-08-30 4/A B $1.47 $17,640 D/D 12,000 40,000 2.74 -
NVIV Invivo Therapeutics Holdi... Acting Chief Financial Officer   •       –      –    2013-09-03 4 B $1.02 $20,400 D/D 20,000 60,000 2.74 -
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2014-11-25 4 B $3.00 $9,150 D/D 3,000 3,000 2.74 -
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2014-11-26 4 B $3.05 $3,050 D/D 1,000 4,000 2.66 -
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2014-12-02 4 B $3.03 $3,030 D/D 1,000 5,000 2.66 -
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2014-12-04 4 B $3.15 $6,400 D/D 2,000 7,000 2.74 -
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2014-12-09 4 B $3.97 $6,764 D/D 1,700 8,700 2.74 -
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2014-12-11 4 B $3.98 $3,980 D/D 1,000 9,700 2.66 -
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2014-12-17 4 B $3.30 $9,875 D/D 2,850 12,550 2.74 -
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2014-12-18 4 B $3.36 $63,168 D/D 18,800 31,350 2.74 -
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2015-06-09 4 B $3.00 $19,500 D/D 6,500 37,850 2.74 -
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2015-08-18 4 B $1.92 $1,916 D/D 1,000 38,850 2.66 -
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2015-08-21 4 B $2.06 $2,879 D/D 1,400 40,250 2.66 -
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2015-09-11 4 B $1.85 $9,234 D/D 5,000 45,250 2.74 -
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2015-09-14 4 B $1.96 $9,820 D/D 5,000 50,250 2.74 -
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2015-09-15 4 B $2.14 $10,720 D/D 5,000 55,250 2.74 -
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2015-09-16 4 B $2.12 $10,605 D/D 5,000 60,250 2.74 -
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2015-11-16 4 B $1.69 $3,372 D/D 2,000 62,250 2.66 -
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2015-11-17 4 B $1.72 $2,583 D/D 1,500 63,750 2.66 -
  61  Records found
  1  2   3      
  Page 1 of 3  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us